- Home
- TWIN vs GNFT Comparison
TWIN vs GNFT Comparison
Compare TWIN & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- GNFT
- Stock Information
- Founded
- TWIN 1918
- GNFT 1999
- Country
- TWIN United States
- GNFT France
- Employees
- TWIN N/A
- GNFT N/A
- Industry
- TWIN Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWIN Industrials
- GNFT Health Care
- Exchange
- TWIN Nasdaq
- GNFT Nasdaq
- Market Cap
- TWIN 152.3M
- GNFT 172.2M
- IPO Year
- TWIN N/A
- GNFT 2019
- Fundamental
- Price
- TWIN $11.39
- GNFT $3.46
- Analyst Decision
- TWIN
- GNFT Strong Buy
- Analyst Count
- TWIN 0
- GNFT 1
- Target Price
- TWIN N/A
- GNFT $13.00
- AVG Volume (30 Days)
- TWIN 26.0K
- GNFT 6.4K
- Earning Date
- TWIN 02-05-2025
- GNFT 09-19-2024
- Dividend Yield
- TWIN 1.44%
- GNFT N/A
- EPS Growth
- TWIN N/A
- GNFT N/A
- EPS
- TWIN 0.68
- GNFT 0.47
- Revenue
- TWIN $304,470,000.00
- GNFT $86,225,222.00
- Revenue This Year
- TWIN N/A
- GNFT $145.20
- Revenue Next Year
- TWIN N/A
- GNFT N/A
- P/E Ratio
- TWIN $16.39
- GNFT $7.17
- Revenue Growth
- TWIN 6.98
- GNFT 175.45
- 52 Week Low
- TWIN $10.22
- GNFT $3.31
- 52 Week High
- TWIN $18.00
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- TWIN 47.47
- GNFT 30.39
- Support Level
- TWIN $10.22
- GNFT $3.35
- Resistance Level
- TWIN $11.86
- GNFT $3.57
- Average True Range (ATR)
- TWIN 0.45
- GNFT 0.11
- MACD
- TWIN -0.03
- GNFT 0.00
- Stochastic Oscillator
- TWIN 63.24
- GNFT 20.00
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.